ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Merck KGaA

Include trials that are no longer recruiting patients.

3 studies were found.
1.RecruitingCilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
Condition: Glioblastoma Multiforme
2.RecruitingA study of the safety and effects of EMD 72000 in subjects with recurrent ovarian cancer
Condition: Ovarian Cancer
3.No longer recruitingSurvival in a Randomized Phase III Trial in Patients with Limited Disease (LD) Small Cell Lung Cancer Vaccinated with Adjuvant BEC2 and BCG
Condition: Carcinoma, Small Cell Lung

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act